- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Odyssey Medical unveils punctal plug, occluder results
Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct.
Memphis, TN
-Odyssey Medical has introduced a punctal plug (Micro Flow) that is designed to provide a reversible means of partial occlusion by limiting the drainage of tears into the lacrimal duct. The device is intended for use in patients who have epiphora caused by a punctal stenosis or in instances where total punctal occlusion is considered too aggressive an approach.
In three sizes (small, medium, and large), the plug is available in sterile pre-loaded packaging that includes one pair of occluders and in non-sterile bulk packaging that includes five pairs.
In other news, the company announced results of a study showing a 92% retention rate for another occluder (Parasol). When Craig McCabe, MD, PhD, examined 108 patients who received the plug after artificial tears had failed to address their dry eye, 91% of them reported that their eyes had more moisture, and 77% reported fewer dry eye symptoms. Snellen acuity improved by one or more lines in 43% of the eyes, according to the company.
